NCT02665923 Gastric Emptying in Neonates and Infants After Formula Feeding
| NCT ID | NCT02665923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Gastric Emptying |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2016-03 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2016-03 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ultrasound imaging will be used to evaluate time for gastric emptying in healthy, fasting newborns, and infants following feeding of clear liquids and/or milk (including breast or formula).
Eligibility Criteria
Inclusion criteria for study cohort are pediatric patients from Allen Hospital and Morgan Stanley Children's Hospital of New York Presbyterian Hospital who are receiving feeding by formula 1. healthy full-term (postmenstrual age ≥ 36 weeks) newborns aged 0-5 days or 2. healthy infants (4-6 months old and 9-12 months old) Exclusion criteria are individuals who have 1. newborn history of requirement resuscitation at delivery 2. newborn history of admission to the Neonatal Intensive Care Unit 3. any history of hospital admission 4. history of gastroesophageal reflux or other feeding difficulty 5. receiving any medication known to accelerate or delay gastric emptying, including but not limited to opioid-containing medications and antacids.
Contact & Investigator
Lena S. Sun, MD
✉ lss4@cumc.columbia.eduLena S. Sun, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT02665923 clinical trial?
This trial is open to participants of all sexes, up to 12 Months, studying Gastric Emptying. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02665923 currently recruiting?
Yes, NCT02665923 is actively recruiting participants. Contact the research team at lss4@cumc.columbia.edu for enrollment information.
Where is the NCT02665923 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT02665923 clinical trial?
NCT02665923 is sponsored by Columbia University. The principal investigator is Lena S. Sun, MD at Columbia University. The trial plans to enroll 210 participants.